ORIGINAL RESEARCH
Published on 17 Aug 2022
Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication
doi 10.3389/fphar.2022.837680
- 3,044 views
- 17 citations
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Idiopathic Pulmonary Fibrosis: Advances in Underlying Mechanisms and Future Perspectives for Therapeutic Interventions
Idiopathic Pulmonary Fibrosis: Advances in Underlying Mechanisms and Future Perspectives for Therapeutic Interventions
6,329
Total downloads
18k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 19 May 2022
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
doi 10.3389/fphar.2022.848263
- 2,753 views
- 8 citations
ORIGINAL RESEARCH
Published on 27 Apr 2022
Immunophenotyping of Acute Inflammatory Exacerbations of Lung Injury Driven by Mutant Surfactant Protein-C: A Role for Inflammatory Eosinophils
doi 10.3389/fphar.2022.875887
- 2,873 views
- 7 citations
OPINION
Published on 14 Apr 2022
IPF-Acute Exacerbations: Advances and Future Perspectives
doi 10.3389/fphar.2022.836553
- 2,135 views
- 3 citations
ORIGINAL RESEARCH
Published on 17 Dec 2021
Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting
doi 10.3389/fphar.2021.790204
- 3,684 views
- 17 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Impact
- 18kTopic views
- 11kArticle views
- 6,329Article downloads